{"entity":{"type":"insider","cik":"0001514291","url":"/insider/0001514291","json_url":"/insider/0001514291.json","name":"Mason Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":53,"n_filings":27,"first":"2012-07-18","last":"2024-09-05","span_basis":"filed_date"},"name_variants":[{"name":"Mason Michael","source":"filing","n_filings":27,"first_seen":"2012-07-18","last_seen":"2024-09-05"}],"transactions":[{"id":2590201,"accession":"0000950170-24-104031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-104031","line_url":"/filing/0000950170-24-104031#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO & Treasurer)","officer_title":"EVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7050.0,"shares_display":"7,050","price_per_share":0.7218,"price_display":"0.72","price_state":"stated","total_value":5088.69,"total_display":"5,088.69","shares_owned_after":391054.0,"shares_owned_after_display":"391,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-04","filed_date":"2024-09-05","scope":"insider"},{"id":2067604,"accession":"0000950170-24-069860","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-069860","line_url":"/filing/0000950170-24-069860#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO & Treasurer)","officer_title":"EVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":652.0,"shares_display":"652","price_per_share":0.99,"price_display":"0.99","price_state":"stated","total_value":645.48,"total_display":"645.48","shares_owned_after":398104.0,"shares_owned_after_display":"398,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-06","scope":"insider"},{"id":2734885,"accession":"0000950170-24-025191","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-025191","line_url":"/filing/0000950170-24-025191#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO & Treasurer)","officer_title":"EVP, CFO & Treasurer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6162.0,"shares_display":"6,162","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":7394.4,"total_display":"7,394.40","shares_owned_after":398756.0,"shares_owned_after_display":"398,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-04","scope":"insider"},{"id":2734880,"accession":"0000950170-24-025191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-025191","line_url":"/filing/0000950170-24-025191#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO & Treasurer)","officer_title":"EVP, CFO & Treasurer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27687.0,"shares_display":"27,687","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":32393.79,"total_display":"32,393.79","shares_owned_after":404918.0,"shares_owned_after_display":"404,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-04","scope":"insider"},{"id":2303013,"accession":"0000950170-24-023292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-023292","line_url":"/filing/0000950170-24-023292#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO & Treasurer)","officer_title":"EVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2545.0,"shares_display":"2,545","price_per_share":1.3238,"price_display":"1.32","price_state":"stated","total_value":3369.071,"total_display":"3,369.07","shares_owned_after":244400.0,"shares_owned_after_display":"244,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-27","filed_date":"2024-02-29","scope":"insider"},{"id":2892567,"accession":"0000950170-24-012832","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-012832","line_url":"/filing/0000950170-24-012832#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO & Treasurer)","officer_title":"EVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4205.0,"shares_display":"4,205","price_per_share":1.5865,"price_display":"1.59","price_state":"stated","total_value":6671.2325,"total_display":"6,671.23","shares_owned_after":246945.0,"shares_owned_after_display":"246,945","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"},{"id":7899292,"accession":"0001209191-23-048162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-048162","line_url":"/filing/0001209191-23-048162#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO & Treasurer)","officer_title":"EVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6913.0,"shares_display":"6,913","price_per_share":1.3313,"price_display":"1.33","price_state":"stated","total_value":9203.2769,"total_display":"9,203.28","shares_owned_after":237817.0,"shares_owned_after_display":"237,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"},{"id":7922301,"accession":"0001209191-23-034262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-034262","line_url":"/filing/0001209191-23-034262#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO & Treasurer)","officer_title":"EVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":631.0,"shares_display":"631","price_per_share":2.22,"price_display":"2.22","price_state":"stated","total_value":1400.82,"total_display":"1,400.82","shares_owned_after":244730.0,"shares_owned_after_display":"244,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-02","filed_date":"2023-06-05","scope":"insider"},{"id":8182893,"accession":"0001209191-23-014843","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-014843","line_url":"/filing/0001209191-23-014843#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO & Treasurer)","officer_title":"EVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11205.0,"shares_display":"11,205","price_per_share":3.0292,"price_display":"3.03","price_state":"stated","total_value":33942.186,"total_display":"33,942.19","shares_owned_after":245361.0,"shares_owned_after_display":"245,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":8744012,"accession":"0001209191-23-014078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-014078","line_url":"/filing/0001209191-23-014078#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO & Treasurer)","officer_title":"EVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2802.0,"shares_display":"2,802","price_per_share":3.0368,"price_display":"3.04","price_state":"stated","total_value":8509.1136,"total_display":"8,509.11","shares_owned_after":161566.0,"shares_owned_after_display":"161,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-03-01","scope":"insider"},{"id":8363332,"accession":"0001209191-23-007775","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007775","line_url":"/filing/0001209191-23-007775#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO & Treasurer)","officer_title":"EVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4141.0,"shares_display":"4,141","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":14079.4,"total_display":"14,079.40","shares_owned_after":164368.0,"shares_owned_after_display":"164,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-08","scope":"insider"},{"id":6443532,"accession":"0000899243-22-021234","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-021234","line_url":"/filing/0000899243-22-021234#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO, Treasurer)","officer_title":"EVP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":598.0,"shares_display":"598","price_per_share":6.04,"price_display":"6.04","price_state":"stated","total_value":3611.92,"total_display":"3,611.92","shares_owned_after":138512.0,"shares_owned_after_display":"138,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-06","scope":"insider"},{"id":6443528,"accession":"0000899243-22-021234","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-021234","line_url":"/filing/0000899243-22-021234#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO, Treasurer)","officer_title":"EVP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3.0,"shares_display":"3","price_per_share":6.067,"price_display":"6.07","price_state":"stated","total_value":18.201,"total_display":"18.20","shares_owned_after":138509.0,"shares_owned_after_display":"138,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-06","scope":"insider"},{"id":6977565,"accession":"0001209191-22-014628","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-014628","line_url":"/filing/0001209191-22-014628#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO & Treasurer)","officer_title":"EVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2398.0,"shares_display":"2,398","price_per_share":10.2375,"price_display":"10.24","price_state":"stated","total_value":24549.525,"total_display":"24,549.52","shares_owned_after":139110.0,"shares_owned_after_display":"139,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider"},{"id":6094920,"accession":"0001209191-22-008126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-008126","line_url":"/filing/0001209191-22-008126#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (EVP, CFO & Treasurer)","officer_title":"EVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3947.0,"shares_display":"3,947","price_per_share":9.862,"price_display":"9.86","price_state":"stated","total_value":38925.314,"total_display":"38,925.31","shares_owned_after":53308.0,"shares_owned_after_display":"53,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider"},{"id":4553929,"accession":"0001209191-21-011488","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-011488","line_url":"/filing/0001209191-21-011488#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (SVP, CFO & Treasurer)","officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2858.0,"shares_display":"2,858","price_per_share":15.5191,"price_display":"15.52","price_state":"stated","total_value":44353.5878,"total_display":"44,353.59","shares_owned_after":5292.0,"shares_owned_after_display":"5,292","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-17","scope":"insider"},{"id":6432824,"accession":"0001325812-18-000004","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001325812-18-000004","line_url":"/filing/0001325812-18-000004#line-14","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16500.0,"shares_display":"16,500","price_per_share":131.2,"price_display":"131.20","price_state":"stated","total_value":2164800.0,"total_display":"2,164,800.00","shares_owned_after":14996.0,"shares_owned_after_display":"14,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-04","filed_date":"2018-01-08","scope":"insider"},{"id":6432822,"accession":"0001325812-18-000004","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001325812-18-000004","line_url":"/filing/0001325812-18-000004#line-13","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12405.0,"shares_display":"12,405","price_per_share":132.18,"price_display":"132.18","price_state":"stated","total_value":1639692.9,"total_display":"1,639,692.90","shares_owned_after":2591.0,"shares_owned_after_display":"2,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-04","filed_date":"2018-01-08","scope":"insider"},{"id":6432819,"accession":"0001325812-18-000004","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001325812-18-000004","line_url":"/filing/0001325812-18-000004#line-12","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5249.0,"shares_display":"5,249","price_per_share":130.42,"price_display":"130.42","price_state":"stated","total_value":684574.58,"total_display":"684,574.58","shares_owned_after":31496.0,"shares_owned_after_display":"31,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-04","filed_date":"2018-01-08","scope":"insider"},{"id":6432813,"accession":"0001325812-18-000004","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001325812-18-000004","line_url":"/filing/0001325812-18-000004#line-11","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1591.0,"shares_display":"1,591","price_per_share":132.98,"price_display":"132.98","price_state":"stated","total_value":211571.18,"total_display":"211,571.18","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-04","filed_date":"2018-01-08","scope":"insider"},{"id":6432808,"accession":"0001325812-18-000004","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001325812-18-000004","line_url":"/filing/0001325812-18-000004#line-10","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":135.0,"price_display":"135.00","price_state":"stated","total_value":81000.0,"total_display":"81,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-04","filed_date":"2018-01-08","scope":"insider"},{"id":6432807,"accession":"0001325812-18-000004","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001325812-18-000004","line_url":"/filing/0001325812-18-000004#line-9","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":133.83,"price_display":"133.83","price_state":"stated","total_value":53532.0,"total_display":"53,532.00","shares_owned_after":600.0,"shares_owned_after_display":"600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-04","filed_date":"2018-01-08","scope":"insider"},{"id":4801965,"accession":"0001553878-17-000013","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001553878-17-000013","line_url":"/filing/0001553878-17-000013#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9375.0,"shares_display":"9,375","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":656250.0,"total_display":"656,250.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-17","scope":"insider"},{"id":8796405,"accession":"0001553878-15-000026","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001553878-15-000026","line_url":"/filing/0001553878-15-000026#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2064.0,"shares_display":"2,064","price_per_share":132.4862,"price_display":"132.49","price_state":"stated","total_value":273451.5168,"total_display":"273,451.52","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-03","scope":"insider"},{"id":8796404,"accession":"0001553878-15-000026","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001553878-15-000026","line_url":"/filing/0001553878-15-000026#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1767.0,"shares_display":"1,767","price_per_share":131.5636,"price_display":"131.56","price_state":"stated","total_value":232472.8812,"total_display":"232,472.88","shares_owned_after":2264.0,"shares_owned_after_display":"2,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-03","scope":"insider"},{"id":8796403,"accession":"0001553878-15-000026","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001553878-15-000026","line_url":"/filing/0001553878-15-000026#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":760.0,"shares_display":"760","price_per_share":130.3921,"price_display":"130.39","price_state":"stated","total_value":99097.996,"total_display":"99,098.00","shares_owned_after":4031.0,"shares_owned_after_display":"4,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-03","scope":"insider"},{"id":8796402,"accession":"0001553878-15-000026","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001553878-15-000026","line_url":"/filing/0001553878-15-000026#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":133.12,"price_display":"133.12","price_state":"stated","total_value":26624.0,"total_display":"26,624.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-03","scope":"insider"},{"id":6714200,"accession":"0001553878-14-000031","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001553878-14-000031","line_url":"/filing/0001553878-14-000031#line-13","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8704.0,"shares_display":"8,704","price_per_share":95.0996,"price_display":"95.10","price_state":"stated","total_value":827746.9184,"total_display":"827,746.92","shares_owned_after":13458.0,"shares_owned_after_display":"13,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6714199,"accession":"0001553878-14-000031","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001553878-14-000031","line_url":"/filing/0001553878-14-000031#line-12","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4128.0,"shares_display":"4,128","price_per_share":95.9674,"price_display":"95.97","price_state":"stated","total_value":396153.4272,"total_display":"396,153.43","shares_owned_after":9330.0,"shares_owned_after_display":"9,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6714197,"accession":"0001553878-14-000031","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001553878-14-000031","line_url":"/filing/0001553878-14-000031#line-11","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":101.747,"price_display":"101.75","price_state":"stated","total_value":203494.0,"total_display":"203,494.00","shares_owned_after":1720.0,"shares_owned_after_display":"1,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6714194,"accession":"0001553878-14-000031","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001553878-14-000031","line_url":"/filing/0001553878-14-000031#line-10","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1835.0,"shares_display":"1,835","price_per_share":100.5161,"price_display":"100.52","price_state":"stated","total_value":184447.0435,"total_display":"184,447.04","shares_owned_after":3720.0,"shares_owned_after_display":"3,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6714191,"accession":"0001553878-14-000031","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001553878-14-000031","line_url":"/filing/0001553878-14-000031#line-9","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1475.0,"shares_display":"1,475","price_per_share":99.7349,"price_display":"99.73","price_state":"stated","total_value":147108.9775,"total_display":"147,108.98","shares_owned_after":5555.0,"shares_owned_after_display":"5,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6714189,"accession":"0001553878-14-000031","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001553878-14-000031","line_url":"/filing/0001553878-14-000031#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":97.1179,"price_display":"97.12","price_state":"stated","total_value":135965.06,"total_display":"135,965.06","shares_owned_after":7930.0,"shares_owned_after_display":"7,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6714187,"accession":"0001553878-14-000031","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001553878-14-000031","line_url":"/filing/0001553878-14-000031#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":102.5622,"price_display":"102.56","price_state":"stated","total_value":92305.98,"total_display":"92,305.98","shares_owned_after":820.0,"shares_owned_after_display":"820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6714184,"accession":"0001553878-14-000031","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001553878-14-000031","line_url":"/filing/0001553878-14-000031#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":98.4833,"price_display":"98.48","price_state":"stated","total_value":88634.97,"total_display":"88,634.97","shares_owned_after":7030.0,"shares_owned_after_display":"7,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6714181,"accession":"0001553878-14-000031","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001553878-14-000031","line_url":"/filing/0001553878-14-000031#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":820.0,"shares_display":"820","price_per_share":103.6001,"price_display":"103.60","price_state":"stated","total_value":84952.082,"total_display":"84,952.08","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6326113,"accession":"0001325812-14-000022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001325812-14-000022","line_url":"/filing/0001325812-14-000022#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2110.0,"shares_display":"2,110","price_per_share":79.0375,"price_display":"79.04","price_state":"stated","total_value":166769.125,"total_display":"166,769.12","shares_owned_after":1637.0,"shares_owned_after_display":"1,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-03","filed_date":"2014-02-04","scope":"insider"},{"id":6326111,"accession":"0001325812-14-000022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001325812-14-000022","line_url":"/filing/0001325812-14-000022#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1540.0,"shares_display":"1,540","price_per_share":78.084,"price_display":"78.08","price_state":"stated","total_value":120249.36,"total_display":"120,249.36","shares_owned_after":3747.0,"shares_owned_after_display":"3,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-03","filed_date":"2014-02-04","scope":"insider"},{"id":6326109,"accession":"0001325812-14-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001325812-14-000022","line_url":"/filing/0001325812-14-000022#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":79.74,"price_display":"79.74","price_state":"stated","total_value":7974.0,"total_display":"7,974.00","shares_owned_after":1537.0,"shares_owned_after_display":"1,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-03","filed_date":"2014-02-04","scope":"insider"},{"id":5516238,"accession":"0001325812-13-000013","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001325812-13-000013","line_url":"/filing/0001325812-13-000013#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5800.0,"shares_display":"5,800","price_per_share":60.2037,"price_display":"60.20","price_state":"stated","total_value":349181.46,"total_display":"349,181.46","shares_owned_after":10047.0,"shares_owned_after_display":"10,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-16","filed_date":"2013-12-18","scope":"insider"},{"id":5516237,"accession":"0001325812-13-000013","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001325812-13-000013","line_url":"/filing/0001325812-13-000013#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":60.7686,"price_display":"60.77","price_state":"stated","total_value":133690.92,"total_display":"133,690.92","shares_owned_after":7847.0,"shares_owned_after_display":"7,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-16","filed_date":"2013-12-18","scope":"insider"},{"id":5489440,"accession":"0001325812-13-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001325812-13-000008","line_url":"/filing/0001325812-13-000008#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1905.0,"shares_display":"1,905","price_per_share":61.5523,"price_display":"61.55","price_state":"stated","total_value":117257.1315,"total_display":"117,257.13","shares_owned_after":9692.0,"shares_owned_after_display":"9,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":5489437,"accession":"0001325812-13-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001325812-13-000008","line_url":"/filing/0001325812-13-000008#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1845.0,"shares_display":"1,845","price_per_share":62.1168,"price_display":"62.12","price_state":"stated","total_value":114605.496,"total_display":"114,605.50","shares_owned_after":7847.0,"shares_owned_after_display":"7,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":5492194,"accession":"0001553878-13-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001553878-13-000023","line_url":"/filing/0001553878-13-000023#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance & Treasurer)","officer_title":"VP, Finance & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14200.0,"shares_display":"14,200","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":710000.0,"total_display":"710,000.00","shares_owned_after":7847.0,"shares_owned_after_display":"7,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-12","filed_date":"2013-07-12","scope":"insider"},{"id":4802342,"accession":"0001553878-13-000021","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001553878-13-000021","line_url":"/filing/0001553878-13-000021#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":480000.0,"total_display":"480,000.00","shares_owned_after":7847.0,"shares_owned_after_display":"7,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-01","filed_date":"2013-07-02","scope":"insider"},{"id":4802337,"accession":"0001553878-13-000021","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001553878-13-000021","line_url":"/filing/0001553878-13-000021#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":384000.0,"total_display":"384,000.00","shares_owned_after":7847.0,"shares_owned_after_display":"7,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-01","filed_date":"2013-07-02","scope":"insider"},{"id":5268639,"accession":"0001553878-13-000020","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001553878-13-000020","line_url":"/filing/0001553878-13-000020#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":29.9327,"price_display":"29.93","price_state":"stated","total_value":389125.1,"total_display":"389,125.10","shares_owned_after":7847.0,"shares_owned_after_display":"7,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-17","filed_date":"2013-06-19","scope":"insider"},{"id":5268637,"accession":"0001553878-13-000020","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001553878-13-000020","line_url":"/filing/0001553878-13-000020#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":29.9327,"price_display":"29.93","price_state":"stated","total_value":187079.375,"total_display":"187,079.38","shares_owned_after":7847.0,"shares_owned_after_display":"7,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-17","filed_date":"2013-06-19","scope":"insider"},{"id":5268635,"accession":"0001553878-13-000020","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001553878-13-000020","line_url":"/filing/0001553878-13-000020#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4375.0,"shares_display":"4,375","price_per_share":29.9327,"price_display":"29.93","price_state":"stated","total_value":130955.5625,"total_display":"130,955.56","shares_owned_after":7847.0,"shares_owned_after_display":"7,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-17","filed_date":"2013-06-19","scope":"insider"},{"id":3352697,"accession":"0001553878-12-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001553878-12-000005","line_url":"/filing/0001553878-12-000005#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001514291","owner_name":"Mason Michael","owner_url":"/insider/0001514291","role":"Officer (VP, Finance and Treasurer)","officer_title":"VP, Finance and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":16.9259,"price_display":"16.93","price_state":"stated","total_value":63472.125,"total_display":"63,472.12","shares_owned_after":7847.0,"shares_owned_after_display":"7,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-30","filed_date":"2012-12-04","scope":"insider"}],"next_cursor":"2012-11-30|3352697","ledger_fault":false,"count":{"value":53,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":53,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":53},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Officer (EVP, CFO & Treasurer)","n_filings":14,"first_seen":"2021-02-17","last_seen":"2024-09-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Officer (VP, Finance and Treasurer)","n_filings":13,"first_seen":"2012-07-18","last_seen":"2018-01-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001514291","retrieved_at":"2026-08-22T02:52:31+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}